Medipharm Labs Corp T.LABS

Interesting news from Avicanna

[mdjbrown]

Trunerox sounds a lot like a generic Epidiolex 

“The approval of our first pharmaceutical product is an exceptionally significant milestone and a major step towards our long-term vision as a biopharmaceutical company with the aim to serve patients with unmet medical needs. It is also rewarding to be able to deliver this medication for such a critical medical condition at an accessible price through our vertical,” stated Aras Azadian, CEO.

The Trunerox drug approval (Registro Sanitario como medicamento) was issued by INVIMA, after a detailed process of verification of all legal, technical, and pharmacological requirements were fulfilled in accordance with Decree 677 of 1995 and other applicable regulations. The approval allows Avicanna to manufacture and commercialize Trunerox in Colombia with approved indications and claims associated to the treatment for seizures related to Lennox-Gastaut Syndrome (LGS) and Dravet Syndrome (DS). Lennox-Gastaut Syndrome (LGS) and Dravet Syndrome (DS) are two of the various, rare epileptic disorders classified as epileptic encephalopathies.


https://www.stockwatch.com/News/Item/Z-C!AVCN-3511533/C/AVCN

[subaru1i]

Trunerox (Epidiolex generic) for Columbia, NOT Brazil but reference 'expanded strategic manufacturing agreement between LABS and Avicanna and ANVISA approvals for LABS.....could be Avicanna's door way into Brazil and not only Columbia.  

[mdjbrown]

s1i, Avicanna may have already solved that conundrum  https://www.avicanna.com/avicanna-and-ease-labs-pharma-granted-commercialization-approval-for-pharmaceutical-preparation-in-brazil/ I think its about time Medipharm names their partners in Brazil / South America, as AVCN had no problem disclosing their partnership with Ease Labs and Aureus years ago and it appears to have paid off.

[subaru1i]

hmmm....perhaps a generic Epidiolex for Canada with LABS?  

[alleyesonme]

Very interesting, 10% Cannabidiol (CBD) as opposed to 90%epidiolex, this drug would fall under 505b2 through FDA application, Avicanna /Labs, close business relationship aforementioned in the expanded partnership agreement announced by avicanna but never mentioned by Labs....also makes you wonder in addition to the medical products coming to Brazil what will be the pharmaceutical drug that Labs

[mdjbrown]

s1i, wouldnt Avicanna make an interesting take-over target for Medipharm considering their current relationship

[subaru1i]

.....is there enough time before DEA?  I could see it after DEA rescheduling.